134 related articles for article (PubMed ID: 38788146)
41. Hemangioblastoma and von Hippel-Lindau disease: genetic background, spectrum of disease, and neurosurgical treatment.
Klingler JH; Gläsker S; Bausch B; Urbach H; Krauss T; Jilg CA; Steiert C; Puzik A; Neumann-Haefelin E; Kotsis F; Agostini H; Neumann HPH; Beck J
Childs Nerv Syst; 2020 Oct; 36(10):2537-2552. PubMed ID: 32507909
[TBL] [Abstract][Full Text] [Related]
42. Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients.
Albiñana V; Villar Gómez de Las Heras K; Serrano-Heras G; Segura T; Perona-Moratalla AB; Mota-Pérez M; de Campos JM; Botella LM
Orphanet J Rare Dis; 2015 Sep; 10():118. PubMed ID: 26394686
[TBL] [Abstract][Full Text] [Related]
43. 68Ga-DOTA-TOC PET/CT of von Hippel-Lindau Disease.
Liberini V; Nicolotti DG; Maccario M; Finessi M; Deandreis D
Clin Nucl Med; 2019 Feb; 44(2):125-126. PubMed ID: 30516678
[TBL] [Abstract][Full Text] [Related]
44. Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor suppressor gene.
Stratmann R; Krieg M; Haas R; Plate KH
J Neuropathol Exp Neurol; 1997 Nov; 56(11):1242-52. PubMed ID: 9370235
[TBL] [Abstract][Full Text] [Related]
45. Review of the Neurological Implications of von Hippel-Lindau Disease.
Dornbos D; Kim HJ; Butman JA; Lonser RR
JAMA Neurol; 2018 May; 75(5):620-627. PubMed ID: 29379961
[TBL] [Abstract][Full Text] [Related]
46. Treatment of recurrent cerebellar hemangioblastoma with external radiotherapy in a patient with von Hippel-Lindau disease: a case report and review of the literature.
Ertas G; Altundag MB; Ucer AR; Cankal F; Altundag K
J Neurooncol; 2005 Jul; 73(3):273-5. PubMed ID: 15980980
[TBL] [Abstract][Full Text] [Related]
47. Novel and recurrent germline mutations in the VHL gene in 5 Arab patients with Von Hippel-Lindau disease.
Faiyaz-Ul-Haque M; Jamil M; Aslam M; Abalkhail H; Al-Dayel F; Basit S; Nawaz Z; Zaidi SHE
Cancer Genet; 2020 May; 243():1-6. PubMed ID: 32179488
[TBL] [Abstract][Full Text] [Related]
48. Experience with indium-111 and yttrium-90-labeled somatostatin analogs.
Virgolini I; Traub T; Novotny C; Leimer M; Füger B; Li SR; Patri P; Pangerl T; Angelberger P; Raderer M; Burggasser G; Andreae F; Kurtaran A; Dudczak R
Curr Pharm Des; 2002; 8(20):1781-807. PubMed ID: 12171531
[TBL] [Abstract][Full Text] [Related]
49. [Von Hippel-Lindau disease: recent genetic progress and patient management. Francophone Study Group of von Hippel-Lindau Disease (GEFVH)].
Richard S; Giraud S; Beroud C; Caron J; Penfornis F; Baudin E; Niccoli-Sire P; Murat A; Schlumberger M; Plouin PF; Conte-Devolx B
Ann Endocrinol (Paris); 1998; 59(6):452-8. PubMed ID: 10189987
[TBL] [Abstract][Full Text] [Related]
50. Molecular genetic analysis of the von Hippel-Lindau disease tumor suppressor gene in familial and sporadic cerebellar hemangioblastomas.
Tse JY; Wong JH; Lo KW; Poon WS; Huang DP; Ng HK
Am J Clin Pathol; 1997 Apr; 107(4):459-66. PubMed ID: 9124215
[TBL] [Abstract][Full Text] [Related]
51. Von Hippel-Lindau disease germline mutations in Mexican patients with cerebellar hemangioblastoma.
Rasmussen A; Nava-Salazar S; Yescas P; Alonso E; Revuelta R; Ortiz I; Canizales-Quinteros S; Tusié-Luna MT; López-López M
J Neurosurg; 2006 Mar; 104(3):389-94. PubMed ID: 16572651
[TBL] [Abstract][Full Text] [Related]
52. Somatostatin receptor 2A expression in von Hippel-Lindau-related hemangioblastomas.
Ahmad S; Muhlebner A; Snijders TJ; de Leng WW; Seute T; van Leeuwaarde RS
Cancer; 2024 Jun; ():. PubMed ID: 38824656
[TBL] [Abstract][Full Text] [Related]
53. von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease.
Vortmeyer AO; Gnarra JR; Emmert-Buck MR; Katz D; Linehan WM; Oldfield EH; Zhuang Z
Hum Pathol; 1997 May; 28(5):540-3. PubMed ID: 9158701
[TBL] [Abstract][Full Text] [Related]
54. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas.
Wizigmann-Voos S; Breier G; Risau W; Plate KH
Cancer Res; 1995 Mar; 55(6):1358-64. PubMed ID: 7533661
[TBL] [Abstract][Full Text] [Related]
55. The utility of
Shell J; Tirosh A; Millo C; Sadowski SM; Assadipour Y; Green P; Patel D; Nilubol N; Kebebew E
Eur J Radiol; 2019 Mar; 112():130-135. PubMed ID: 30777201
[TBL] [Abstract][Full Text] [Related]
56. [Analysis of spinal cord hemangioblastoma in von Hippel-Lindau disease].
Nakashima H; Tokunaga K; Tamiya T; Matsumoto K; Ohmoto T; Furuta T
No Shinkei Geka; 1999 Jun; 27(6):533-40. PubMed ID: 10396736
[TBL] [Abstract][Full Text] [Related]
57. A case report of cerebellar hemangioblastoma simulated brain metastasis shown by magnetic resonance imaging.
Xue J; Mo C
Medicine (Baltimore); 2024 Feb; 103(6):e37162. PubMed ID: 38335432
[TBL] [Abstract][Full Text] [Related]
58. Clinicopathological study of vascular endothelial growth factor (VEGF), p53, and proliferative potential in familial von Hippel-Lindau disease and sporadic hemangioblastomas.
Miyagami M; Katayama Y; Nakamura S
Brain Tumor Pathol; 2000; 17(3):111-20. PubMed ID: 11310918
[TBL] [Abstract][Full Text] [Related]
59. Radiologic Characteristics of Spinal Hemangioblastomas in von Hippel Lindau Disease as Guidance in Clinical Interventions.
Mossel P; van der Horst-Schrivers ANA; Olderode-Berends MJW; Groen RJM; Hoving EW; Appelman APA; Links TP
World Neurosurg; 2022 Dec; 168():e67-e75. PubMed ID: 36126890
[TBL] [Abstract][Full Text] [Related]
60. Recurrent multiple CNS hemangioblastomas with VHL disease treated with pazopanib: a case report and literature review.
Migliorini D; Haller S; Merkler D; Pugliesi-Rinaldi A; Koka A; Schaller K; Leemann B; Dietrich PY
CNS Oncol; 2015; 4(6):387-92. PubMed ID: 26497655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
